Oxana Beskrovnaya, Chief Scientific Officer at Dyne Therapeutics, Inc. (DYN), sold 59,707 shares at $32.49 ($2.0M) on 2024-05-20, disclosed to the SEC on 2024-05-22.
Scheduled sale ($2.0M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.49 | 17,134 | $557K | 28.3% |
| 2 | $32.49 | 17,134 | $557K | 28.3% |
| 3 | $33.51 | 12,147 | $407K | 20.7% |
| 4 | $33.51 | 12,147 | $407K | 20.7% |
| 5 | $34.08 | 1,145 | $39K | 2.0% |
| Total | $32.94 avg | 59,707 |
| $2.0M |
| 100% |
| Filing → |
| DYN | SELL | 2025-02-25 | $36K | — | Filing → |
| DYN | SELL | 2024-12-11 | $131K | — | Filing → |
| DYN | SELL | 2024-11-18 | $161K | — | Filing → |